Vivus (VVUS +1.3%) moves up today after quietly disclosing in an 8-K with the SEC disclosing...

|By:, SA News Editor

Vivus (VVUS +1.3%) moves up today after quietly disclosing in an 8-K with the SEC disclosing that its weight-loss drug Qsymia was available in the U.S. market. The announcement was also made on its website, Qsymia.com. Peer competitor Arena Pharmaceuticals (ARNA +1%) also gets a lift on the news, in spite of the fact that its weight-loss drug, Belviq, won't be available until 2013.